Therapeutic agent injection device
A therapeutic agent injection device including an injection device for delivering a therapeutic agent to a patient having a body, the body having a patient face and a port face opposite the patient face, the port face having an introducer port including an introducer channel and an injection port including an injection channel, the introducer channel being in fluid communication with the injection channel through a cross channel, the injection channel defining an injection axis; a delivery tube for subcutaneous delivery of the therapeutic agent to the patient, the delivery tube projecting from and being generally perpendicular to the patient face, the delivery tube defining an introducer axis and being in fluid communication with the injection port; and a patch, the patch being attached to the patient face and being operable to adhesively attach to the patient; wherein the injection axis is parallel to the introducer axis.
1. An injection device for delivering a therapeutic agent to a patient, the injection device comprising:
a body having a patient face and a port face opposite the patient face, the port face having an introducer port including an introducer channel and an injection port including an injection channel, the injection channel defining a single injection axis, a cross channel connecting the introducer channel to the injection channel, the introducer channel being in fluid communication with the injection channel through the cross channel;
a delivery tube for subcutaneous delivery of the therapeutic agent to the patient, the delivery tube projecting from and being generally perpendicular to the patient face, the delivery tube defining a single introducer axis and being in fluid communication with the injection port;
wherein the injection axis is parallel to and does not intersect the introducer axis;
a patch attached to the patient face and operable to adhesively attach to the patient; and
a pop-up indicator disposed in the introducer channel, the pop-up indicator having a normal state when pressure in the introducer channel is normal and an alarm state when pressure in the introducer channel exceeds a predetermined value.
2. The injection device of claim 1 , wherein the pop-up indicator includes a self-closing port operable to receive a needle of a needle hub assembly.
3. The injection device of claim 1 , wherein the pop-up indicator has a membrane selected from the group consisting of a folded membrane, an accordion membrane, and a deformable membrane.
4. The injection device of claim 1 , the cross channel defining a single cross channel axis, wherein the cross channel axis intersects both the injection axis and the introducer axis.
5. The injection device of claim 4 , wherein the cross channel axis is substantially perpendicular to both the injection axis and the introducer axis.
6. The injection device of claim 1 , wherein the cross channel connects an end of the injection channel that is distal to the injection port and an end of the introducer channel that is proximate to the introducer port.
7. An injection device for delivering a therapeutic agent to a patient, the injection device comprising:
a body having a patient face and a port face opposite the patient face, the port face having an introducer port including an introducer channel and an injection port including an injection channel, the injection channel defining a single injection axis, a cross channel connecting the introducer channel to the injection channel, the introducer channel being in fluid communication with the injection channel through the cross channel;
a delivery tube for subcutaneous delivery of the therapeutic agent to the patient, the delivery tube projecting from and being generally perpendicular to the patient face, the delivery tube defining a single introducer axis and being in fluid communication with the injection port;
wherein the injection axis is parallel to and does not intersect the introducer axis;
a patch attached to the patient face and operable to adhesively attach to the patient; and
wherein the body has a first body portion including the port face and a second body portion including the patient face, the first body portion and the second body portion being rotatably connected with a flange, the first body portion and the second body portion being independently rotatable about the introducer axis.
8. The injection device of claim 7 , the cross channel defining a single cross channel axis, wherein the cross channel axis intersects both the injection axis and the introducer axis.
9. The injection device of claim 8 , wherein the cross channel axis is substantially perpendicular to both the injection axis and the introducer axis.
10. The injection device of claim 7 , wherein the cross channel connects an end of the injection channel that is distal to the injection port and an end of the introducer channel that is proximate to the introducer port.
11. An injection device for delivering a therapeutic agent to a patient, the injection device comprising:
a body having a patient face and a port face opposite the patient face, the port face having an introducer port including an introducer channel and an injection port including an injection channel, the injection channel defining a single injection axis, a cross channel connecting the introducer channel to the injection channel, the introducer channel being in fluid communication with the injection channel through the cross channel;
a delivery tube for subcutaneous delivery of the therapeutic agent to the patient, the delivery tube projecting from and being generally perpendicular to the patient face, the delivery tube defining a single introducer axis and being in fluid communication with the injection port;
wherein the injection axis is parallel to and does not intersect the introducer axis;
a patch attached to the patient face and operable to adhesively attach to the patient; and
an injection septum.
12. The injection device of claim 11 , the cross channel defining a single cross channel axis, wherein the cross channel axis intersects both the injection axis and the introducer axis.
13. The injection device of claim 12 , wherein the cross channel axis is substantially perpendicular to both the injection axis and the introducer axis.
14. The injection device of claim 11 , wherein the cross channel connects an end of the injection channel that is distal to the injection port and an end of the introducer channel that is proximate to the introducer port.
15. An injection device for delivering a therapeutic agent to a patient, the injection device comprising:
a body having a patient face and a port face opposite the patient face, the port face having an introducer port including an introducer channel and an injection port including an injection channel, a cross channel connecting the introducer channel to the injection channel, wherein the cross channel connects an end of the injection channel that is distal to the injection port to an end of the introducer channel that is proximate to the introducer port, the introducer channel being in fluid communication with the injection channel through the cross channel, the cross channel defining a single cross channel axis and the injection channel defining a single injection axis;
a delivery tube for subcutaneous delivery of the therapeutic agent to the patient, the delivery tube projecting from and being generally perpendicular to the patient face, the delivery tube defining a single introducer axis and being in fluid communication with the injection port;
a patch attached to the patient face and operable to adhesively attach to the patient; and
an injection adapter assembly connectable to the injection port, the injection adapter assembly being operable to receive a needleless pen injector;
wherein the injection axis is parallel to and does not intersect the introducer axis; and
wherein the cross channel axis is substantially perpendicular to and intersects both the injection axis and the introducer axis.